Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Phase 1
Completed
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-08-26
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Cancer Treatment Centers of America
- Target Recruit Count
- 30
- Registration Number
- NCT00003406
- Locations
- 🇺🇸
Midwestern Regional Medical Center, Zion, Illinois, United States
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Phase 2
Completed
- Conditions
- Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorKidney CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNeuroblastomaOvarian Cancer
- First Posted Date
- 2003-05-23
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Cancer Treatment Centers of America
- Target Recruit Count
- 40
- Registration Number
- NCT00003408
- Locations
- 🇺🇸
Midwestern Regional Medical Center, Zion, Illinois, United States
News
No news found